Quoin Pharmaceuticals, Ltd. (QNRX) — DEFA14A Filings
All DEFA14A filings from Quoin Pharmaceuticals, Ltd.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
Quoin Pharmaceuticals Files Proxy Statement
— Apr 2, 2024 Risk: low
Quoin Pharmaceuticals, Ltd. (formerly Cellect Biotechnology Ltd. and Cellect Biomed Ltd.) is filing a Definitive Proxy Statement (DEFA14A) on April 2, 2024. Thi
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX